Correlation Between Serum GDF11 Levels and the Progression of Ischemic Mitral Regurgitation and Long-term Prognosis

Jiangping Ye1,2, Kewei Zong3, Yehong Liu2

  • 1The Second People's Hospital of Changzhou, The Third Affiliated Hospital of Nanjing Medical University, Changzhou, Jiangsu, People's Republic of China.

Insights

Growth Differentiation Factor 11 (GDF11) levels predict worsening ischemic mitral regurgitation (IMR) and heart failure in ST-elevation myocardial infarction (STEMI) patients after percutaneous coronary intervention (pPCI). Higher GDF11 indicates a better prognosis.

Area of Science:

  • Cardiology
  • Biomarkers
  • Regenerative Medicine

Background:

  • Ischemic mitral regurgitation (IMR) is a frequent complication in ST-elevation myocardial infarction (STEMI) patients undergoing percutaneous coronary intervention (pPCI).
  • Growth Differentiation Factor 11 (GDF11), a known cardiovascular protective factor, has a potential role in modulating IMR progression and patient outcomes.

Purpose of the Study:

  • To investigate the predictive value of serum GDF11 levels for IMR exacerbation and cardiac function post-pPCI in STEMI patients.
  • To assess GDF11 as a prognostic biomarker for heart failure development in this patient cohort.

Main Methods:

  • Serum GDF11 levels were measured pre-pPCI in 310 STEMI patients.
  • Cox regression, ROC analysis, and Spearman's correlation were employed to analyze the association between GDF11, IMR progression, and cardiac function (including LVEF and left atrial dimensions).

Main Results:

  • Lower serum GDF11 levels significantly predicted IMR worsening (HR=0.982, P=0.004) and were associated with reduced cardiac function.
  • Higher GDF11 levels correlated with reduced IMR progression (P=0.0013) and lower risk of heart failure (P=0.0003).
  • GDF11 levels showed significant correlation with LVEF and left atrial changes (P<0.05).

Conclusions:

  • Serum GDF11 is an independent predictor of IMR exacerbation and post-pPCI heart failure in STEMI patients.
  • GDF11 serves as a valuable prognostic biomarker for assessing cardiovascular outcomes in STEMI patients complicated by IMR.

Related Concept Videos

Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
596
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
358
Mitral Regurgitation IV: Nursing Management01:28

Mitral Regurgitation IV: Nursing Management

Mitral regurgitation (MR) is a condition where the mitral valve does not close properly, leading to the backward flow of blood from the left ventricle into the left atrium during systole. This condition can arise from various causes, including rheumatic fever, infective endocarditis, or degenerative valve disease. Effective nursing management is crucial to optimizing patient outcomes and involves comprehensive assessment and targeted interventions.Comprehensive Patient AssessmentA detailed...
357
Mitral Regurgitation II: Clinical Features and Diagnostic Tests01:23

Mitral Regurgitation II: Clinical Features and Diagnostic Tests

Mitral regurgitation (MR) is a valvular heart disorder in which the mitral valve fails to close tightly, allowing blood to leak backward into the heart. Understanding the clinical manifestations, assessment, diagnostic findings, and medical management of MR is crucial to effectively managing affected patients.Clinical Manifestations of Mitral RegurgitationMitral regurgitation can be acute or chronic, each presenting differently and requiring different approaches:1. Acute Mitral...
505
Freezing Point Depression and Boiling Point Elevation03:12

Freezing Point Depression and Boiling Point Elevation

Boiling Point Elevation
The boiling point of a liquid is the temperature at which its vapor pressure is equal to ambient atmospheric pressure. Since the vapor pressure of a solution is lowered due to the presence of nonvolatile solutes, it stands to reason that the solution’s boiling point will subsequently be increased. Vapor pressure increases with temperature, and so a solution will require a higher temperature than will pure solvent to achieve any given vapor pressure, including one...
40.3K
Correlations02:20

Correlations

Correlation means that there is a relationship between two or more variables (such as ice cream consumption and crime), but this relationship does not necessarily imply cause and effect. When two variables are correlated, it simply means that as one variable changes, so does the other. We can measure correlation by calculating a statistic known as a correlation coefficient. A correlation coefficient is a number from -1 to +1 that indicates the strength and direction of the relationship between...
36.3K